Nome |
# |
Transformed follicular lymphoma, file e31e124d-2acf-987f-e053-3705fe0a095a
|
3.539
|
Peripheral T-Cell Lymphomas: Incorporating New Developments in Diagnostics, Prognostication, and Treatment Into Clinical Practice-PART 1: PTCL-NOS, FTCL, AITL, ALCL, file e31e124d-78e9-987f-e053-3705fe0a095a
|
2.790
|
Follicular lymphoma international prognostic index., file e31e124c-38ff-987f-e053-3705fe0a095a
|
1.543
|
Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY.12, file e31e124b-3355-987f-e053-3705fe0a095a
|
1.525
|
Malattia celiaca e linfoma, file e31e124c-4abd-987f-e053-3705fe0a095a
|
1.043
|
Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 Trial, file e31e124b-362a-987f-e053-3705fe0a095a
|
747
|
R-CVP versus R-CHOP versus R-FM for the initial treatment of patients with advanced-stage follicular lmphoma: results of the FOLL05 trial conducted by the Fondazione Italiana Linfomi, file e31e124b-35f7-987f-e053-3705fe0a095a
|
745
|
The italian multi-center project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk, file e31e124c-44b6-987f-e053-3705fe0a095a
|
729
|
Hairy cell leukemia: a reversible disease? A report of two cases of spontaneous remission, file e31e124c-5fe4-987f-e053-3705fe0a095a
|
684
|
Tumor burden in Hodgkin's lymphoma can be reliably estimated from a few staging parameters., file e31e124b-e814-987f-e053-3705fe0a095a
|
673
|
Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project, file e31e124b-2342-987f-e053-3705fe0a095a
|
658
|
Breast cancer screening in women at increased risk according to different family histories: an update of the Modena Study Group experience, file e31e124c-1ddb-987f-e053-3705fe0a095a
|
636
|
Long-Term Results of the FOLL05 Trial Comparing R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Symptomatic Follicular Lymphoma, file e31e124d-248f-987f-e053-3705fe0a095a
|
609
|
Castleman's lymphoadenopathy: twenty years of observation. II. Generalized form, file e31e124c-5e65-987f-e053-3705fe0a095a
|
576
|
PRIMARY GASTROINTESTINAL LYMPHOMA - A CLINICOPATHOLOGICAL STUDY OF 58 CASES, file e31e124c-610f-987f-e053-3705fe0a095a
|
562
|
Daily variation of immunoreactive serum interleukin-6 levels in multiple myeloma, file e31e124c-4922-987f-e053-3705fe0a095a
|
559
|
Complete remission in a case of aplastic anemia after treatment with antilymphocyte globulin, file e31e124c-5b2e-987f-e053-3705fe0a095a
|
551
|
Splenic marginal zone lymphoma: a prognostic model for clinical use., file e31e124c-28b2-987f-e053-3705fe0a095a
|
536
|
Patogenesi complessa di una emopatia sistemica: la tricoleucemia, file e31e124c-62f4-987f-e053-3705fe0a095a
|
536
|
Enteropathy-associated T-cell lymphoma: clinical and histological findings from the International Peripheral T-cell Lymphoma Project, file e31e124b-25d9-987f-e053-3705fe0a095a
|
530
|
Penetrances of breast and ovarian cancer in a large series of families tested for BRCA1/2 mutations, file e31e124c-3c5a-987f-e053-3705fe0a095a
|
525
|
STIFF-MAN SYNDROME IN A PATIENT WITH HODGKINS-DISEASE - AN UNUSUAL PARANEOPLASTIC SYNDROME, file e31e124c-8860-987f-e053-3705fe0a095a
|
525
|
Cancer incidence in eastern Libya: The first report from the Benghazi Cancer Registry, 2003, file e31e124c-21ef-987f-e053-3705fe0a095a
|
524
|
Incidence of AIDS-Defining cancers after AIDS diagnosis among people with AIDS in Italy, 1986-1998, file e31e124c-46ba-987f-e053-3705fe0a095a
|
520
|
T-cell lymphomas: where we are and where we a re moving forward, file e31e124b-ae23-987f-e053-3705fe0a095a
|
515
|
Peripheral T-Cell Lymphomas: Incorporating New Developments in Diagnostics, Prognostication, and Treatment Into Clinical Practice-PART 2: ENKTL, EATL, Indolent T-Cell LDP of the GI Tract, ATLL, and Hepatosplenic T-Cell Lymphoma, file e31e124d-7944-987f-e053-3705fe0a095a
|
506
|
Usefulness of breast MRI in a patient with genetic risk, file e31e124c-4443-987f-e053-3705fe0a095a
|
487
|
Hairy Cell Leukemia. A therapeutical update, file e31e124c-7eb0-987f-e053-3705fe0a095a
|
483
|
Sindrome mediastinica da mieloblastoma quale manifestazione d'esordio di leucemia mieloide acuta, file e31e124c-5e6b-987f-e053-3705fe0a095a
|
482
|
Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study, file e31e124c-38d9-987f-e053-3705fe0a095a
|
478
|
Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study, file e31e124b-2e13-987f-e053-3705fe0a095a
|
473
|
Relationship between prognostic factors and therapy in high grade non Hodgkin's lymphomas over two decades, file e31e124c-787c-987f-e053-3705fe0a095a
|
468
|
Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial, file e31e124f-7d67-987f-e053-3705fe0a095a
|
462
|
EPIDOXORUBICIN VS IDARUBICIN CONTAINING REGIMENS IN INTERMEDIATE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA - PRELIMINARY-RESULTS OF A MULTICENTRIC RANDOMIZED TRIAL, file e31e124c-57f6-987f-e053-3705fe0a095a
|
458
|
Hereditary risk of breast cancer: not only brca, file e31e124c-39af-987f-e053-3705fe0a095a
|
409
|
Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe, file e31e124c-45df-987f-e053-3705fe0a095a
|
381
|
A multicenter retrospective clinical study of CD5/CD10-negative chronic B cell leukemias., file e31e124c-142a-987f-e053-3705fe0a095a
|
361
|
Induction chemotherapy stategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients., file e31e124c-42a6-987f-e053-3705fe0a095a
|
357
|
Estimated and observed cancer incidence in Italy: a validation study, file e31e124c-2406-987f-e053-3705fe0a095a
|
352
|
Monocyte count at diagnosis is a prognostic parameter in diffuse large B-cell lymphoma: a large multicenter study involving 1191 patients, in the pre and post rituximab era, file e31e124b-2d72-987f-e053-3705fe0a095a
|
343
|
Cancer profile in Eastern Libya: incidence and mortality in the year 2004., file e31e124c-0fc1-987f-e053-3705fe0a095a
|
317
|
Estimates of cancer burden in Italy, file e31e124b-e645-987f-e053-3705fe0a095a
|
316
|
Reevaluation of prognostic significance of symptoms in Hodgkin's disease, file e31e124c-62ee-987f-e053-3705fe0a095a
|
316
|
Interim PET-CT scan in advanced Hodgkin's lymphoma, file e31e124b-d986-987f-e053-3705fe0a095a
|
310
|
Epidemiological overview of Hodgkin lymphoma across the Mediterranean Basin, file e31e124b-b2fa-987f-e053-3705fe0a095a
|
297
|
Serum albumin in Hodgkin's disease, file e31e124c-62ea-987f-e053-3705fe0a095a
|
291
|
Multicenter comparative multimodality surveillance of women at genetic-familial risk for breast cancer (HIBCRIT study): interim results., file e31e124c-1d00-987f-e053-3705fe0a095a
|
276
|
External validation on a prospective basis of a nomogram for predicting the time to first treatment in patients with chronic lymphocytic leukemia, file e31e124b-2b17-987f-e053-3705fe0a095a
|
271
|
Pattern of cancer risk in person with AIDS in Italy inthe HAART era, file e31e124c-191d-987f-e053-3705fe0a095a
|
253
|
High-dose sequential chemotherapy and peripheral blood progenitor cell autografting in patients with refractory and/or recurrent Hodgkin lymphoma - A multicenter study of the Intergruppo Italiano Linfomi showing prolonged disease free survival in patients, file e31e124c-3a2a-987f-e053-3705fe0a095a
|
251
|
Prognosis of screen-detected breast cancers: results of a population based study, file e31e124c-2706-987f-e053-3705fe0a095a
|
246
|
IMPACT Working Group: effectiveness of service screening: a case-control study to assess breast cancer mortalità reduction., file e31e124c-239c-987f-e053-3705fe0a095a
|
243
|
Positron-emission tomography–based staging reduces the prognostic impact of early disease progression in patients with follicular lymphoma, file e31e124e-572e-987f-e053-3705fe0a095a
|
241
|
ESMO guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL), file e31e124b-2a31-987f-e053-3705fe0a095a
|
238
|
International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017), file e31e124c-b85f-987f-e053-3705fe0a095a
|
238
|
Minimal residual disease after conventional treatment significantly impacts on progression-free survival of patients with follicular lymphoma: The FIL FOLL05 trial, file e31e124b-ecdf-987f-e053-3705fe0a095a
|
233
|
Breast Carcinoma Survival in Europe and the United States: A Population-Based Study, file e31e124c-42d9-987f-e053-3705fe0a095a
|
231
|
Screen-detected vs clinical breast cancer: the advantage in the relative risk of lymph node metastases decreases with increasing tumour size, file e31e124c-38c5-987f-e053-3705fe0a095a
|
230
|
Total body computed tomography scan in the initial work-up of binet stage a chronic lymphocytic leukemia patients: results of the prospective, multicenter o-cll1-gisl study, file e31e124b-2e10-987f-e053-3705fe0a095a
|
228
|
Absolute monocyte count and lymphocyte-monocyte ratio predict outcome in nodular sclerosis Hodgkin lymphoma: Evaluation based on data from 1450 patients, file e31e124b-b230-987f-e053-3705fe0a095a
|
227
|
Tumor size, node status, grading, HER2 and estrogen receptor status still retain a strong value in patients with operable breast cancer diagnosed in recent years., file e31e124b-2ed2-987f-e053-3705fe0a095a
|
225
|
Castleman's lymphoadenopathy: twenty years of observation. I. General considerations. Monodenopathic variety, file e31e124c-5e67-987f-e053-3705fe0a095a
|
224
|
The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi, file e31e124b-2fa6-987f-e053-3705fe0a095a
|
223
|
Absolute monocyte count at diagnosis could improve the prognostic role of early FDG-PET in classical Hodgkin lymphoma patients, file e31e124b-fb99-987f-e053-3705fe0a095a
|
222
|
Brentuximab vedotin followed by ABVD +/- radiotherapy in patients with previously untreated Hodgkin lymphoma: final results of a pilot phase II study, file e31e124b-f0fd-987f-e053-3705fe0a095a
|
216
|
The prognostic role of post-induction FDG-PET in patients with follicular lymphoma: a subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi (FIL), file e31e124b-29b3-987f-e053-3705fe0a095a
|
213
|
Estimates of cancer burden in Emilia-Romagna, file e31e124b-eb18-987f-e053-3705fe0a095a
|
213
|
The outcome of peripheral t-cell lymphoma patients failing first-line therapy: A report from the prospective, international t-cell project, file e31e124d-73b4-987f-e053-3705fe0a095a
|
212
|
Splenosis peritonei., file e31e124c-3951-987f-e053-3705fe0a095a
|
210
|
Reply to T.P. Vassilakopoulos et al, file e31e124b-d07d-987f-e053-3705fe0a095a
|
209
|
Relevance of stereotyped B-cell receptors in the context of the molecular, cytogenetic and clinical features of chronic lymphocytic leukemia., file e31e124b-22d6-987f-e053-3705fe0a095a
|
207
|
Second malignancies after treatment of diffuse large B-cell non-Hodgkin's lymphoma: a GISL cohort study, file e31e124c-1499-987f-e053-3705fe0a095a
|
205
|
ABVD versus Stanford V versus MEC in unfavourable Hodgkin's lymphoma: results of a randomised trial, file e31e124c-4e4f-987f-e053-3705fe0a095a
|
203
|
Positron emission tomography response and minimal residual disease impact on progression-free survival in patients with follicular lymphoma. A subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi, file e31e124b-d98f-987f-e053-3705fe0a095a
|
200
|
A diachronic-comparative analysis for the identification of the most powerful prognostic index for localized diffuse large B-cell lymphoma, file e31e124b-3166-987f-e053-3705fe0a095a
|
196
|
Do We Need Maintenance with Anti-CD20 Antibody after First-Line Therapy for All Newly Diagnosed Follicular Lymphoma Patients?, file e31e124e-848f-987f-e053-3705fe0a095a
|
194
|
Secondary malignant neoplasms, progression-free survival and overall survival in patients treated for Hodgkin lymphoma: A systematic review and meta-analysis of randomized clinical trials, file e31e124d-2039-987f-e053-3705fe0a095a
|
193
|
Risk for second malignancies in non-Hodgkin's lymphoma survivors: a meta-analysis, file e31e124b-22d8-987f-e053-3705fe0a095a
|
191
|
Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). A new prognostic model developed by the International T cell Project Network, file e31e124d-7125-987f-e053-3705fe0a095a
|
191
|
Vinblastine, bleomycin, and methotrexate chemotherapy plus irradiation for patients with early-stage, favorable Hodgkin lymphoma - The experience of the gruppo italiano studio linfomi, file e31e124c-38c8-987f-e053-3705fe0a095a
|
190
|
Chromosome 2p gain in monoclonal B-cell lymphocytosis and in early stage chronic lymphocytic leukemia., file e31e124b-2e82-987f-e053-3705fe0a095a
|
188
|
The role of dose size in a chemotherapy regimen (ProMECE-CytaBOM) for the first-line treatment of large B-cell lymphomas: a randomized trial by the Gruppo Italiano Studio Linfomi (GISL), file e31e124c-38be-987f-e053-3705fe0a095a
|
188
|
Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma, file e31e124c-42df-987f-e053-3705fe0a095a
|
188
|
Response-Adapted Postinduction Strategy in Patients With Advanced-Stage Follicular Lymphoma: The FOLL12 Study, file e31e1250-848f-987f-e053-3705fe0a095a
|
188
|
Risk assessment in diffuse large cell lymphoma at first relapse. A study by the Italian Intergroup for Lymphomas., file e31e124c-49ce-987f-e053-3705fe0a095a
|
186
|
High-dose therapy and autologous stem cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy: long-term results., file e31e124c-115e-987f-e053-3705fe0a095a
|
185
|
MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors, file e31e124c-24b4-987f-e053-3705fe0a095a
|
183
|
Rituximab in combination with fludarabine and cyclophosphamide in the treatment of patients with recurrent follicular lymphoma, file e31e124c-20c3-987f-e053-3705fe0a095a
|
180
|
Ovarian cancer: can proteomics give new insights for therapy and diagnosis?, file e31e124b-2c28-987f-e053-3705fe0a095a
|
178
|
ABVD plus radiotherapy versus EVE plus radiotherapy in unfavorable stage IA and IIA Hodgkin's lymphoma: results from an Intergruppo Italiano Linfomi randomized study., file e31e124c-1495-987f-e053-3705fe0a095a
|
177
|
Bone marrow stem cell damage after three different chemotherapy regimens for advanced Hodgkin's lymphoma, file e31e124c-16e4-987f-e053-3705fe0a095a
|
175
|
Adapted treatment guided by interim PET-CT scan in advanced Hodgkin's lymphoma, file e31e124b-a985-987f-e053-3705fe0a095a
|
173
|
Case studies of elderly patients with non-Hodgkin's lymphoma., file e31e124b-1b18-987f-e053-3705fe0a095a
|
170
|
Sensitive detection of circulating breast cancer cells by reverse-transcriptase polymerase chain reaction of maspin gene, file e31e124c-4bb7-987f-e053-3705fe0a095a
|
170
|
The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who do not benefit from doxorubicin: FIL-FOLL study, file e31e124b-b234-987f-e053-3705fe0a095a
|
169
|
Italian family with two independent mutations:3358T/A in BRCA1 and 8756delA in BRCA2 genes., file e31e124c-3903-987f-e053-3705fe0a095a
|
168
|
Mastectomy rates are decreasing in the era of service screening: a population-based study in Italy (1997-2001), file e31e124c-39e8-987f-e053-3705fe0a095a
|
166
|
Anthracyclines: a cornerstone in the management of non-Hodgkin's lymphoma., file e31e124b-2138-987f-e053-3705fe0a095a
|
162
|
Survival outcomes for extranodal natural-killer T-cell lymphoma – Authors' reply, file e31e124e-9791-987f-e053-3705fe0a095a
|
162
|
Prognostic value of morphology and hormone receptor status in breast cancer - a population based study, file e31e124c-42db-987f-e053-3705fe0a095a
|
161
|
Totale |
41.787 |